205 related articles for article (PubMed ID: 21270130)
1. Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass.
Hoeppner LH; Secreto FJ; Razidlo DF; Whitney TJ; Westendorf JJ
J Biol Chem; 2011 Apr; 286(13):10950-9. PubMed ID: 21270130
[TBL] [Abstract][Full Text] [Related]
2. Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation.
Hoeppner LH; Secreto F; Jensen ED; Li X; Kahler RA; Westendorf JJ
J Cell Physiol; 2009 Nov; 221(2):480-9. PubMed ID: 19650108
[TBL] [Abstract][Full Text] [Related]
3. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter.
Kahler RA; Westendorf JJ
J Biol Chem; 2003 Apr; 278(14):11937-44. PubMed ID: 12551949
[TBL] [Abstract][Full Text] [Related]
4. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
5. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
[TBL] [Abstract][Full Text] [Related]
6. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice.
Harrison JR; Huang YF; Wilson KA; Kelly PL; Adams DJ; Gronowicz GA; Clark SH
J Biol Chem; 2005 Mar; 280(9):8117-24. PubMed ID: 15598659
[TBL] [Abstract][Full Text] [Related]
7. Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation.
Kahler RA; Yingst SM; Hoeppner LH; Jensen ED; Krawczak D; Oxford JT; Westendorf JJ
Matrix Biol; 2008 May; 27(4):330-8. PubMed ID: 18280717
[TBL] [Abstract][Full Text] [Related]
8. The pro-osteogenic action of beta-catenin requires interaction with BMP signaling, but not Tcf/Lef transcriptional activity.
Salazar VS; Mbalaviele G; Civitelli R
J Cell Biochem; 2008 Jun; 104(3):942-52. PubMed ID: 18247340
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation.
Mbalaviele G; Sheikh S; Stains JP; Salazar VS; Cheng SL; Chen D; Civitelli R
J Cell Biochem; 2005 Feb; 94(2):403-18. PubMed ID: 15526274
[TBL] [Abstract][Full Text] [Related]
10. Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.
Yang M; Trettel LB; Adams DJ; Harrison JR; Canalis E; Kream BE
Bone; 2010 Sep; 47(3):573-82. PubMed ID: 20541046
[TBL] [Abstract][Full Text] [Related]
11. PITX2 and beta-catenin interactions regulate Lef-1 isoform expression.
Amen M; Liu X; Vadlamudi U; Elizondo G; Diamond E; Engelhardt JF; Amendt BA
Mol Cell Biol; 2007 Nov; 27(21):7560-73. PubMed ID: 17785445
[TBL] [Abstract][Full Text] [Related]
12. OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling.
Feigin ME; Malbon CC
Cell Signal; 2008 May; 20(5):949-57. PubMed ID: 18296023
[TBL] [Abstract][Full Text] [Related]
13. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts.
Kahler RA; Galindo M; Lian J; Stein GS; van Wijnen AJ; Westendorf JJ
J Cell Biochem; 2006 Apr; 97(5):969-83. PubMed ID: 16267835
[TBL] [Abstract][Full Text] [Related]
15. Guhong Injection promotes fracture healing by activating Wnt/beta-catenin signaling pathway in vivo and in vitro.
Sun Z; Jin H; Zhou H; Yu L; Wan H; He Y
Biomed Pharmacother; 2019 Dec; 120():109436. PubMed ID: 31561068
[TBL] [Abstract][Full Text] [Related]
16. A Reciprocal Interaction between β-Catenin and Osterix in Cementogenesis.
Choi H; Kim TH; Yang S; Lee JC; You HK; Cho ES
Sci Rep; 2017 Aug; 7(1):8160. PubMed ID: 28811640
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1.
Chan SC; Hajarnis SS; Vrba SM; Patel V; Igarashi P
J Biol Chem; 2020 Dec; 295(51):17560-17572. PubMed ID: 33453998
[TBL] [Abstract][Full Text] [Related]
18. General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.
Yu S; Jiang Y; Galson DL; Luo M; Lai Y; Lu Y; Ouyang HJ; Zhang J; Xiao G
J Biol Chem; 2008 Feb; 283(9):5542-53. PubMed ID: 18171674
[TBL] [Abstract][Full Text] [Related]
19. Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical Wnt signaling through interactions with β-catenin.
Salazar VS; Zarkadis N; Huang L; Watkins M; Kading J; Bonar S; Norris J; Mbalaviele G; Civitelli R
J Cell Sci; 2013 Dec; 126(Pt 24):5598-609. PubMed ID: 24101723
[TBL] [Abstract][Full Text] [Related]
20. Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression.
Arce L; Pate KT; Waterman ML
BMC Cancer; 2009 May; 9():159. PubMed ID: 19460168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
